Composition, useful to treat e.g. a morbid change to or an irritation of the prostate, comprises a first active agent (alpha antagonists or 5-alpha reductase inhibitors) and a second active agent (beta-3-adrenoceptor agonists)

摘要

Composition (A) comprises a first active agent (I) (comprising one or more alpha antagonists (a) or 5-alpha reductase inhibitors (b)) and a second active agent (II) (comprising one or more beta-3-adrenoceptor agonists (c)) and their salt, enantiomer, diastereomer, tautomer or metabolite. ACTIVITY : Uropathic. MECHANISM OF ACTION : Alpha antagonist; 5-Alpha reductase inhibitor; Beta-3-adrenoceptor agonist. No biological data given.